Imperial College London
Mr Duncan Spalding

MrDuncanSpalding

Faculty of Medicine, Department of Surgery & Cancer

Clinical Senior Lecturer in Hepato-Biliary Surgery
 
 
 
//

Contact

 

+44 (0)20 3313 3941d.spalding

 
 
//

Location

 

Hammersmith HospitalHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@inproceedings{D'Alessio:2022,
author = {D'Alessio, A and Pai, M and Spalding, D and Rajagopal, P and Talbot, T and Goldin, R and Fulgenzi, CAM and Ward, C and Yip, V and Slater, S and Sodergren, M and Tait, P and Habib, NA and Thomas, R and Cortellini, A and Sharma, R and Pinato, DJJ},
publisher = {LIPPINCOTT WILLIAMS & WILKINS},
title = {Preliminary results from a phase Ib study of neoadjuvant ipilimumab plus nivolumab prior to liver resection for hepatocellular carcinoma: The PRIME-HCC trial.},
url = {https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000863680301257&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb},
year = {2022}
}
Download

RIS format (EndNote, RefMan)

TY  - CPAPER
AU  - D'Alessio,A
AU  - Pai,M
AU  - Spalding,D
AU  - Rajagopal,P
AU  - Talbot,T
AU  - Goldin,R
AU  - Fulgenzi,CAM
AU  - Ward,C
AU  - Yip,V
AU  - Slater,S
AU  - Sodergren,M
AU  - Tait,P
AU  - Habib,NA
AU  - Thomas,R
AU  - Cortellini,A
AU  - Sharma,R
AU  - Pinato,DJJ
PB  - LIPPINCOTT WILLIAMS & WILKINS
PY  - 2022///
SN  - 0732-183X
TI  - Preliminary results from a phase Ib study of neoadjuvant ipilimumab plus nivolumab prior to liver resection for hepatocellular carcinoma: The PRIME-HCC trial.
UR  - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000863680301257&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
ER  -
Download